Emflaza
Deflazacort
Empaquetado | Per comprimido | Precio | Ahorro | Order |
---|---|---|---|---|
120 tablet
Free AirMail shipping
Hot
|
$ 4700.46
|
$ 564054.95$ 4700.46
|
$ 102359.64
|
|
90 tablet
Free AirMail shipping
Hot
|
$ 4956.73
|
$ 446105.47$ 4956.73
|
$ 53705.48
|
|
60 tablet
Free AirMail shipping
Hot
|
$ 5127.38
|
$ 307643.03$ 5127.38
|
$ 25564.27
|
|
36 tablet
Free AirMail shipping
Hot
|
$ 5411.72
|
$ 194821.78$ 5411.72
|
$ 5102.60
|
|
24 tablet
|
$ 5553.45
|
$ 133282.92$ 5553.45
|
|
Empaquetado | Per comprimido | Precio | Ahorro | Order |
---|---|---|---|---|
90 tablet
Free AirMail shipping
Hot
|
$ 5697.47
|
$ 512772.57$ 5697.47
|
$ 102423.74
|
|
60 tablet
Free AirMail shipping
Hot
|
$ 6153.03
|
$ 369181.89$ 6153.03
|
$ 40948.98
|
|
36 tablet
Free AirMail shipping
Hot
|
$ 6551.32
|
$ 235847.69$ 6551.32
|
$ 10230.84
|
|
24 tablet
Free AirMail shipping
Hot
|
$ 6835.51
|
$ 164052.35$ 6835.51
|
|
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.